McKenzie LJ

No ORCID on file · 3 papers in corpus
2026
Novel anti-Mullerian hormone receptor 2 binding peptide prevents chemotherapy-related ovarian follicle loss in a mouse model.
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-026-03902-5

PurposeCancer treatments can deplete the ovarian follicle reserve causing infertility and early menopause, with subsequent decline in cardiovascular, cognitive, and overall health. Medical measures to prevent this chemotherapy-induced ovari…

review 2026
The role of anti-Müllerian hormone as a therapeutic agent to preserve the ovarian follicle pool during chemotherapy
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-026-03941-y

PURPOSE: Cancer treatments can deplete the ovarian follicle reserve, causing infertility and early menopause, with subsequent decline in cardiovascular, cognitive, and overall women's health. Medical measures to prevent this chemotherapy-in…

2022
A Case-Control Study of Follicular Fluid Cytokine Profiles in Women with Diminished Ovarian Reserve.
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-021-00757-2

Ovarian reserve is an important determinant of a woman's reproductive potential, and women with diminished ovarian reserve (DOR) often seek in vitro fertilization (IVF). The underlying etiology of DOR is unknown, but follicular fluid cytoki…